These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6396067)

  • 21. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cisplatin].
    Ogawa M
    Gan To Kagaku Ryoho; 1984 May; 11(5):1140-6. PubMed ID: 6326687
    [No Abstract]   [Full Text] [Related]  

  • 23. [First therapeutic experience with cis-platinum(II)diamindichloride (NSC 119875) in metastasizing ovarian and testicular carcinoma].
    Cavalli F; Sonntag RW; Ryssel HJ; Tschopp L; Brunner KW
    Schweiz Med Wochenschr; 1976 May; 106(22):754-7. PubMed ID: 996494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paclitaxel (Taxol): a review of its antitumor activity in clinical studies Minireview.
    Hájek R; Vorlicek J; Slavik M
    Neoplasma; 1996; 43(3):141-54. PubMed ID: 8841500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy of advanced ovarian cancer.
    Martoni A; Cacciari N; Angelelli B; Zamagni C; Pannuti F
    Front Biosci; 1997 Mar; 2():g20-6. PubMed ID: 9159262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ifosfamide in the treatment of ovarian cancer.
    Markman M
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):47-9. PubMed ID: 8677449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase II evaluation of tirapazamine plus cisplatin in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study.
    Covens A; Blessing J; Bender D; Mannel R; Morgan M;
    Gynecol Oncol; 2006 Mar; 100(3):586-90. PubMed ID: 16249022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cis-diamminedichloroplatinum(II). A new antineoplastic agent derived from the group of heavy metal complexes (author's transl)].
    Osieka R; Schmidt CG
    Klin Wochenschr; 1979 Dec; 57(23):1249-58. PubMed ID: 121143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paclitaxel pharmacology and other tumor types.
    Rowinsky EK
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-1-S19-12. PubMed ID: 9427257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topotecan in platinum- and paclitaxel-resistant ovarian cancer.
    Swisher EM; Mutch DG; Rader JS; Elbendary A; Herzog TJ
    Gynecol Oncol; 1997 Sep; 66(3):480-6. PubMed ID: 9299264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cis-diamminedichloroplatinum (II). A new anticancer drug.
    Rozencweig M; von Hoff DD; Slavik M; Muggia FM
    Ann Intern Med; 1977 Jun; 86(6):803-12. PubMed ID: 326117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New options for the treatment of advanced ovarian cancer.
    Dunton CJ
    Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-2-S5-11. PubMed ID: 9122739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model.
    Saucier JM; Yu J; Gaikwad A; Coleman RL; Wolf JK; Smith JA
    J Oncol Pharm Pract; 2007 Mar; 13(1):39-45. PubMed ID: 17621566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients.
    Merrin CE
    Cancer Treat Rep; 1979; 63(9-10):1579-84. PubMed ID: 574057
    [No Abstract]   [Full Text] [Related]  

  • 37. Overview of platinum chemotherapy in head and neck cancer.
    Forastiere AA
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):20-7. PubMed ID: 7527591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinoma.
    Hanauske AR; Schilling T; Heinrich B; Kau R; Herzog M; Quasthoff S; Bochtler H; Diergarten K; Rastetter J
    Semin Oncol; 1995 Dec; 22(6 Suppl 14):35-9. PubMed ID: 8553082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continued chemosensitivity to cisplatin/carboplatin in ovarian carcinoma despite treatment with multiple prior platinum-based regimens.
    Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
    Gynecol Oncol; 1997 Jun; 65(3):434-6. PubMed ID: 9190971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers.
    Muggia FM
    Semin Oncol; 2004 Dec; 31(6 Suppl 14):17-24. PubMed ID: 15726530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.